🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Removal

Based on the social media company, the platform has taken down violative content and banned associated hashtags and query recommendations. The organization said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also found communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of joining one group, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Information and Costs

Within these groups, posts display dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.